Fibronectin-containing ophthalmic solution, method of preserving

Details Fibronectin-containing ophthalmic solution, method of preserving Fibronectin-containing ophthalmic solution, method of preserving

1994-06-01

1996-05-07

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514912, A61K 3710

Patent

active

055146473

ABSTRACT:
A stable and soluble multi-dose ophthalmic solution is disclosed. The solution contains fibronectin, an amino acid, a sugar, and a lower alkyl p-hydroxybenzoate. A method treatment of ophthalmic wounds employing the ophthalmic solution, a process for preparing fibronectin for ophthalmic use, a method of lyophilizing an aqueous solution of fibronectin free of albumin, a method for inhibiting bacterial growth in an ophthalmic solution while preserving the cellular adhesion and wound healing activities of fibronectin, and a method of treatment of ophthalmic wounds administering a wound-healing accelerator solution are also disclosed.

REFERENCES:
patent: 4565651 (1986-01-01), Ohmura
patent: 4740498 (1988-04-01), Hirao et al.
patent: 4837019 (1989-06-01), Georgalas et al.
patent: 4841023 (1989-06-01), Horowitz
Stern, M. E. et al., "The Effects of Human Recombinant Epidermal Growth Factor on Epithelial Wound Healing," Healing Processes in the Cornea, pp. 69-77 (C. E. Crosson and H. E. Kaufman, Eds.) (1989).
Countois, Y. et al., 181 C R. Soc. Biol., pp. 491-495 (1987).
Horowitz, B. and Chang, N. Y., "Preparation of Fibronectin for Therapeutic Administration", Fibronectin, pp. 441-455 (Deane S. Mosher, Ed.) (1989).
Moses, R. et al., 18 Invest Ophthamal 103-106 (1979).
Nishida, T., et al., 102 Arch. Opthamal 455-456 (1984).
Assouline, M. et al., "Fibroblast Growth Factor Effects on Corneal Wound Healing in the Rabbit", Healing Processes in the Cornea, pp. 79-97 (C. E. Crosson and H. E. Kaufman, Eds.) (1989).
Mullen, W. et al., Survey of Ophtalmology, 17:469-483 (1973).
Nelson, J. D., et al., Am. J. of Opthal. 114:441-447 (1992).
The USP, vol. XXI, p. 1339, "General Information/Pharmaceutical Dosage Forms"1985.
Chemical Abstracts, vol. 11, No. 10, p. 368, col. 1, Shiseido Co., Ltd., "Cosmetics containing fibronectin" (Sep. 3, 1984).
Gottfried, N. S., "Alkali p-Hydroxybenzoate Esters as Pharmaceutical Preservatives", Am. J. Hosp. Pharm., 19:310-314 (1962).

Affiliated with

Also associated with

Rating

Fibronectin-containing ophthalmic solution, method of preserving does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fibronectin-containing ophthalmic solution, method of preserving, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibronectin-containing ophthalmic solution, method of preserving will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1227224